Metraipolis › archive › dc_0411ce30883a

Intralesional bevacizumab as an adjuvant approach to recurrent respiratory papillomatosis: A prospective study on different treatment protocols — Europe PMC PMID:41701700

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41701700
DOI
10.1371/journal.pone.0342749
License (as archived)
solo-consultazione
Archived
2026-11-05T16:59:48.734Z
SHA-256 of the archived text
7264c2b8a7feb7c858a0834296dca3f5c59c5370f0a1bc2a33d3461f5c02ffbe
Stable URL of this page
https://metraipolis.com/documento/dc_0411ce30883a

How to cite

Intralesional bevacizumab as an adjuvant approach to recurrent respiratory papillomatosis: A prospective study on different treatment protocols — Europe PMC PMID:41701700 — Europe PMC (en), https://europepmc.org/article/MED/41701700 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0411ce30883a (Metraipolis archive dc_0411ce30883a, sha256 7264c2b8a7feb7c858a0834296dca3f5c59c5370f0a1bc2a33d3461f5c02ffbe)
BibTeX
@misc{dc0411ce30883a,
  title = {Intralesional bevacizumab as an adjuvant approach to recurrent respiratory papillomatosis: A prospective study on different treatment protocols — Europe PMC PMID:41701700},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41701700},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0411ce30883a; sha256 7264c2b8a7feb7c858a0834296dca3f5c59c5370f0a1bc2a33d3461f5c02ffbe},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41701700. Agents can read the archived copy with the MCP tool read_document.